Financials

  • Market Capitalization 557.55 M
  • Employee 231
  • Founded 2005
  • CEO Linda Marban
  • Website www.capricor.com
  • Headquarter Delaware, United States
  • FIGI BBG000DZMK99
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.77
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2831
MPLT
MapLight Therapeutics, Inc. - Common Stock
12.60 USD+0.48%+12.40%-16.94%-33.68%584.36 M USD
2855
VALN
Valneva SE - American Depositary Shares
6.43 USD-2.28%-3.74%+27.08%-20.22%557.93 M USD
2860
DRUG
Bright Minds Biosciences Inc. - common stock
72.81 USD-2.32%-5.50%+1.70%+85.83%555.96 M USD
2863
PROK
ProKidney Corp. - Class A Ordinary Shares
1.83 USD+0.55%+15.09%+19.61%-12.02%553.25 M USD

Frequently asked questions about Capricor Therapeutics Inc

What is the Capricor Therapeutics Inc stock price today?

The current price of Capricor Therapeutics Inc (CAPR) is 9.59. Over the past 24 hours, the stock has changed by -4.67%. Follow the CAPR chart for real-time price dynamics.

What is the stock ticker of Capricor Therapeutics Inc?

Capricor Therapeutics Inc trades under the ticker CAPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Capricor Therapeutics Inc stock going up?

CAPR has changed by +19.58% over the last week, +212.38% over the last month, and +53.19% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Capricor Therapeutics Inc?

Capricor Therapeutics Inc currently has a market capitalization of 557.55 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Capricor Therapeutics Inc earnings last quarter?

Last quarter, Capricor Therapeutics Inc reported earnings of -0.7 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Capricor Therapeutics Inc revenue for the last quarter?

Capricor Therapeutics Inc reported quarterly revenue of 2 271. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Capricor Therapeutics Inc net income for the last quarter?

Capricor Therapeutics Inc reported net income of -40.73 M for the last quarter. The previous quarter showed -33.94 M, which means net income changed by -20.01%.

How many employees does Capricor Therapeutics Inc have?

As of the latest available data, Capricor Therapeutics Inc has 231 employees. Workforce size can provide additional context about the company's scale and operations.

What is Capricor Therapeutics Inc EBITDA?

Capricor Therapeutics Inc EBITDA is -42.38 M, and its EBITDA margin is -1.87 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Capricor Therapeutics Inc stock?

You can buy Capricor Therapeutics Inc (CAPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Capricor Therapeutics Inc stock?

Investing in Capricor Therapeutics Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CAPR chart and related analysis on metatrader.com as part of your research.

News